W. Dieter Paar

Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: A sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients

Ulrich Kintscher, Peter Bramlage, W. Dieter Paar et al. · Cardiovascular Diabetology · 2007 · 98 citations · Full text

Ramipril-based versus diuretic-based antihypertensive primary treatment in patients with pre-diabetes (ADaPT) study

Walter Zidek, Joachim Schrader, Stephan Lüders et al. · Cardiovascular Diabetology · 2012 · 94 citations · Full text

A Global Perspective on Blood Pressure Treatment and Control in a Referred Cohort of Hypertensive Patients

Peter Bramlage, Michael Böhm, Massimo Volpe et al. · Journal of Clinical Hypertension · 2010 · 91 citations · Full text

Hypertension, Heart Failure, Preventive Cardiology +23

Influence of the angiotensin converting enzyme inhibitor ramipril on high-sensitivity C-reactive protein (hs-CRP) in patients with documented atherosclerosis

Veselin Mitrović, H. H. Klein, N. Krekel et al. · Zeitschrift für Kardiologie · 2005 · 31 citations

Inflammation, Thrombosis, Hypertension +13

PEARL: A Non-interventional Study of Real-World Alirocumab Use in German Clinical Practice

Klaus G. Parhofer, Berndt von Stritzky, Nicole Pietschmann et al. · Drugs - Real World Outcomes · 2019 · 23 citations · Full text